Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison
Authors:
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Primary Multiplication Site of the Vaccinia-rabies Glycoprotein Recombinant Virus Administered to Foxes by the Oral RouteJournal of General Virology, 1990
- USE OF RECOMBINANT VACCINIA-RABIES GLYCOPROTEIN VIRUS FOR ORAL VACCINATION OF WILDLIFE AGAINST RABIES: INNOCUITY TO SEVERAL NON-TARGET BAIT CONSUMING SPECIESJournal of Wildlife Diseases, 1989
- Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult miceVirology, 1989
- Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoproteinArchives of Virology, 1988
- Oral vaccination of the fox against rabies using a live recombinant vaccinia virusNature, 1986
- Oral immunization against rabies with an avirulent mutant of the CVS strain: Evaluation of its efficacy in fox (Vulpes vulpes) and its infectivity in seven other speciesAnnales de l'Institut Pasteur / Virologie, 1985
- Expression of rabies virus glycoprotein from a recombinant vaccinia virusNature, 1984
- The binding of staphylococcal protein A by the sera of different animal species.The Journal of Immunology, 1982
- Small mammal studies in a SAD baiting areaComparative Immunology, Microbiology and Infectious Diseases, 1982
- ORAL RABIES VACCINE: EVALUATION OF ITS INFECTIVITY IN THREE SPECIES OF RODENTSAmerican Journal of Epidemiology, 1976